INDICATIONS     CONTRA-INDICATIONS     DOSAGE     SIDE-EFFECTS     PREGNANCY     OVERDOSE     IDENTIFICATION     PATIENT INFORMATION

Logo PLENISH-K®Tablets

SCHEDULING STATUS:
S2

PROPRIETARY NAME
(and dosage form):

PLENISH-K®Tablets

COMPOSITION:
Each tablet contains 600 mg
potassium chloride in a slow release core.

PHARMACOLOGICAL CLASSIFICATION:
A 24 Mineral substitutes, electrolytes.

PHARMACOLOGICAL ACTION:
The tablets are especially formulated in a slow-release core to minimise the possibility of gastro-intestinal irritation which may arise from a localised high concentration of potassium in the gut. Potassium is of fundamental importance in the ionic exchange of cellular metabolism. Potassium is the predominating cation of the intracellular fluid and erythrocytes.

INDICATIONS:
Potassium chloride tablets are used in the treatment of potassium deficiency which may arise due to diuretic therapy, hypochloraemic alkalosis, diabetic acidosis or steroid therapy. There is no proof that the dosage of potassium chloride contained in this medicine will necessarily serve to prevent a meaningful loss of potassium or normalise an existing shortage of potassium.

CONTRA-INDICATIONS:
Hyperkalaemia, ulceration of the bowel.

DOSAGE AND DIRECTIONS FOR USE:
As an adjunct to diuretic therapy: 2 to 6 tablets daily.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Nausea, vomiting, diarrhoea and abdominal cramps may rarely occur. Intestinal ulceration has been reported. Caution should be observed in treating patients with renal or adrenal insufficiency, acute dehydration or heat cramp. In the presence of reduced renal function hyperkalaemia may be produced.

KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
Excessive doses may cause hyperkalaemia with paraesthesia of the extremities, mental confusion, paralysis, hypotension, cardiac arrhythmias, heart block and cardiac arrest.
Treatment of overdosage is symptomatic.

IDENTIFICATION:
White, deep biconvex, sugar coated tablets.

PRESENTATION:
Packs of 100 and 500 tablets.

STORAGE INSTRUCTIONS:
Store below 25°C.
Protect from moisture.
KEEP OUT OF REACH OF CHILDREN.

REGISTRATION NUMBER:
L/24/417

NAME AND BUSINESS ADDRESS OF APPLICANT:
Pharmacare Limited, Building 12,
Healthcare Park, Woodlands Drive, Woodmead,
Sandton, 2148

DATE OF PUBLICATION OF THIS PACKAGE INSERT:
05/1981.
                A226
                A & S PRINTERS

Updated on this site: April 2005
Source: Hospital Pharmacy

SAEPI HOME PAGE      TRADE NAME INDEX      GENERIC NAME INDEX      FEEDBACK
Information presented by Malahyde Information Systems © Copyright 1996-2005